In 2023, the UK pharmaceutical industry export market share was 4.78%. From 2024 to 2028, forecasts show a consistent decline. Year-on-year, the market share decreases by approximately 4.61% between 2024 and 2025, and by 4.61% again from 2025 to 2026. The projected decline continues with a 4.82% drop from 2026 to 2027 and 5.32% from 2027 to 2028. The Compound Annual Growth Rate (CAGR) over the five-year span indicates an average annual decrease of about 4.57%.
Future trends to watch for include potential impacts from regulatory changes post-Brexit, global economic shifts, advancements in pharmaceutical technology, and emerging markets that could influence the UK's market share dynamics.
